SB 752 North Carolina Senate · 2025-2026 Session

Needle Free Epinephrine for Schoolchildren.

SB 752 allows North Carolina schools to use epinephrine nasal spray in addition to auto-injectors for treating severe allergic reactions (anaphylaxis). The bill requires schools to stock at least two emergency epinephrine products (including nasal spray) in secure but accessible locations, train staff to recognize symptoms and administer treatment, and develop emergency action plans. It applies to all public, charter, and regional schools, directly affecting students with severe allergies and school staff trained to respond to emergencies. The policy change takes effect for the 2025-2026 school year.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 25, 2025 Last action Mar 26, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Filed Edition 1 · 3 edits
MINOR
The bill text has been updated from a draft filing version to an official edition, with minor formatting changes and one substantive addition regarding diabetes care plan implementation in charter schools. The document now includes proper session headers, bill numbering, and a specific reference to state education statutes.
Scope change
The bill's scope remains focused on allowing epinephrine nasal spray use in schools, but now explicitly requires that diabetes care plan guidelines be implemented in charter schools.
TECHNICAL

Header formatting changed from draft filing version to official edition with proper session information and bill number

Removed draft document identifiers and preliminary filing information

REQUIREMENT

Added requirement that diabetes care plan guidelines under G.S. 115C-12(31) must be implemented in charter schools

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
1
Mar 26, 2025
Committee
Ref To Com On Rules and Operations of the Senate
upper
Mar 25, 2025
Introduced
Filed
upper
2 primary · 5 co-sponsors

Sponsors